ACET
Adicet Bio, Inc.Company with tickers: ACET
CIK
1720580
CUSIP
007002207
Shares Outstanding
9,348,236
13F Activity (30d)
36 filings
36 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. |
Director | Other | 250,000 |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. |
Director | Other | 250,000 |
| 2026-04-08 | ORBIMED ADVISORS LLC |
10% Owner | Sell | 40,416 |
| 2026-04-08 | ORBIMED ADVISORS LLC |
10% Owner | Sell | 32,523 |
| 2026-04-07 | ORBIMED ADVISORS LLC |
10% Owner | Sell | 29,319 |
| 2026-04-07 | ORBIMED ADVISORS LLC |
10% Owner | Other | 564,147 |
| 2026-04-07 | ORBIMED ADVISORS LLC |
10% Owner | Other | 78,499 |
| 2026-04-07 | ORBIMED ADVISORS LLC |
10% Owner | Sell | 2,400 |
| 2026-04-07 | ORBIMED ADVISORS LLC |
10% Owner | Other | 280,640 |
| 2026-03-25 | Harvey Brian Nicholas |
Chief Financial Officer | Award | 43,361 |
| 2026-03-25 | Schor Chen |
Director, President & CEO | Award | 468,555 |
| 2026-03-25 | Maltzman Julia D. |
Chief Medical Officer | Award | 72,555 |
| 2026-03-25 | Aftab Blake |
Chief Scientific Officer | Award | 72,555 |
| 2026-03-25 | Healey Don |
Chief Technology Officer | Award | 43,361 |
| 2026-02-20 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 74,751 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 74,268 |
| 2026-02-18 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 74,577 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. |
Director | Other | 0 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. |
Director | Other | 959,028 |
| 2026-01-24 | Harvey Brian Nicholas |
Chief Financial Officer | Tax | 546 |
| 2026-01-24 | Schor Chen |
Director, President & CEO | Tax | 1,755 |
| 2026-01-24 | Schor Chen |
Director, President & CEO | Other | 3,339 |
| 2026-01-24 | Healey Don |
Chief Technology Officer | Tax | 535 |
| 2026-01-24 | Schor Chen |
Director, President & CEO | Other | 2,716 |
| 2026-01-24 | Aftab Blake |
Chief Scientific Officer | Tax | 535 |
| 2025-10-08 | ORBIMED ADVISORS LLC |
10% Owner | Other | 1,255,985 |
| 2025-10-08 | ORBIMED ADVISORS LLC |
10% Owner | Other | 1,027,885 |
| 2025-10-08 | ORBIMED ADVISORS LLC |
10% Owner | Buy | 3,500,000 |
| 2025-10-08 | ORBIMED ADVISORS LLC |
10% Owner | Other | 646,657 |
| 2025-10-08 | ORBIMED ADVISORS LLC |
10% Owner | Buy | 1,500,000 |
| 2025-06-11 | Peng Katie |
Director | Award | 5,900 |
| 2025-06-11 | Klickstein Lloyd |
Director | Award | 26,400 |
| 2025-06-11 | Sinclair Andrew |
Director | Award | 26,400 |
| 2025-06-11 | Chodakewitz Jeffrey |
Director | Award | 5,900 |
| 2025-06-11 | DUBIN STEVE |
Director | Award | 26,400 |
| 2025-06-11 | Klickstein Lloyd |
Director | Award | 5,900 |
| 2025-06-11 | Sinclair Andrew |
Director | Award | 5,900 |
| 2025-06-11 | DUBIN STEVE |
Director | Award | 5,900 |
| 2025-06-11 | Chodakewitz Jeffrey |
Director | Award | 26,400 |
| 2025-06-11 | Peng Katie |
Director | Award | 26,400 |
| 2025-04-17 | Grissinger Michael |
Director | Other | 0 |
| 2025-04-17 | Grissinger Michael |
Director | Award | 70,200 |
| 2025-01-31 | Maltzman Julia D. |
Chief Medical Officer | Award | 750,000 |
| 2025-01-31 | Harvey Brian Nicholas |
Chief Financial Officer | Award | 324,040 |
| 2025-01-31 | Schor Chen |
Director, President & CEO | Award | 763,829 |
| 2025-01-31 | Aftab Blake |
Chief Scientific Officer | Award | 275,000 |
| 2025-01-31 | Healey Don |
Chief Technology Officer | Award | 275,000 |
| 2025-01-24 | Aftab Blake |
Chief Scientific Officer | Tax | 6,270 |
| 2025-01-24 | Harvey Brian Nicholas |
Chief Financial Officer | Tax | 8,752 |
| 2025-01-24 | Schor Chen |
Director, President & CEO | Tax | 28,101 |
Showing 1–50 of 581 transactions